Published in J Endocrinol on October 01, 2002
Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A (2004) 2.99
Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol (2003) 2.73
The influences of diet and exercise on mental health through hormesis. Ageing Res Rev (2007) 1.34
Impact of laparoscopic sleeve gastrectomy on body mass index, ghrelin, insulin and lipid levels in 100 obese patients. Wideochir Inne Tech Maloinwazyjne (2012) 1.16
Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol (2013) 1.10
Ghrelin hyporesponsiveness contributes to age-related hyperinflammation in septic shock. Ann Surg (2009) 0.96
Serum ghrelin concentrations in patients receiving olanzapine or risperidone. Psychopharmacology (Berl) (2003) 0.90
The role of ghrelin in GH secretion and GH disorders. Mol Cell Endocrinol (2011) 0.88
The ghrelin axis in disease: potential therapeutic indications. Mol Cell Endocrinol (2011) 0.87
Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease. Peptides (2011) 0.86
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice. Genes Nutr (2009) 0.85
Improved serum leptin and ghrelin following bariatric surgery predict better postoperative cognitive function. J Clin Neurol (2015) 0.83
Fasting ghrelin is related to skeletal muscle mass in healthy adults. Eur J Nutr (2009) 0.83
Age-dependent decline in acyl-ghrelin concentrations and reduced association of acyl-ghrelin and growth hormone in healthy older adults. J Clin Endocrinol Metab (2013) 0.81
Severely obese adolescents and adults exhibit a different association of circulating levels of adipokines and leukocyte expression of the related receptors with insulin resistance. Int J Endocrinol (2013) 0.81
Exercise training modifies ghrelin and adiponectin concentrations and is related to inflammation in older adults. J Gerontol A Biol Sci Med Sci (2013) 0.80
Mechanisms of the anorexia of aging-a review. Age (Dordr) (2015) 0.78
Synchronizing an aging brain: can entraining circadian clocks by food slow Alzheimer's disease? Front Aging Neurosci (2014) 0.77
A New Strategy Using Rikkunshito to Treat Anorexia and Gastrointestinal Dysfunction. Evid Based Complement Alternat Med (2015) 0.77
Caloric restriction stimulates autophagy in rat cortical neurons through neuropeptide Y and ghrelin receptors activation. Aging (Albany NY) (2016) 0.76
Anorexia of aging and gut hormones. Aging Dis (2013) 0.76
Understanding the gastrointestinal tract of the elderly to develop dietary solutions that prevent malnutrition. Oncotarget (2015) 0.76
CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's Disease. J Alzheimers Dis Parkinsonism (2013) 0.76
From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation. Int J Mol Sci (2017) 0.76
Ageing Is Associated with Decreases in Appetite and Energy Intake-A Meta-Analysis in Healthy Adults. Nutrients (2016) 0.75
The relationship between serum ghrelin levels and hair zinc concentrations in children. J Clin Res Pediatr Endocrinol (2008) 0.75
Obestatin is associated to muscle strength, functional capacity and cognitive status in old women. Age (Dordr) (2013) 0.75
Therapeutic Potential of Targeting the Ghrelin Pathway. Int J Mol Sci (2017) 0.75
Malnutrition Markers and Serum Ghrelin Levels in Hemodialysis Patients. Int Sch Res Notices (2014) 0.75
Ghrelin Gene Variants Influence on Metabolic Syndrome Components in Aged Spanish Population. PLoS One (2015) 0.75
The role of ghrelin, salivary secretions, and dental care in eating disorders. Nutrients (2012) 0.75
Ghrelin, anthropometry and nutritional assessment in geriatric hospital patients. Z Gerontol Geriatr (2007) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab (2000) 2.27
A child with phenotypic Laron dwarfism and normal somatomedin levels. N Engl J Med (1989) 2.08
Transcranial direct current stimulation improves recognition memory in Alzheimer disease. Neurology (2008) 1.83
Sympathetic activation in obese normotensive subjects. Hypertension (1995) 1.78
Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation (1998) 1.60
Consensus statement: medical management of acromegaly. Eur J Endocrinol (2005) 1.54
Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration. J Clin Endocrinol Metab (1974) 1.50
Guidelines for acromegaly management. J Clin Endocrinol Metab (2002) 1.48
Correction and withdrawal of conclusion--a child with phenotypic Laron dwarfism and normal somatomedin levels. N Engl J Med (1990) 1.46
Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab (1999) 1.46
Urinary free cortisol is unrelated to physiological changes in urine volume in healthy women. Clin Chem (2000) 1.46
Growth hormone in obesity. Int J Obes Relat Metab Disord (1999) 1.43
Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide. Eur J Endocrinol (2001) 1.38
Behavioral symptoms in mild cognitive impairment. Neurology (2004) 1.36
Sulfatides trigger increase of cytosolic free calcium and enhanced expression of tumor necrosis factor-alpha and interleukin-8 mRNA in human neutrophils. Evidence for a role of L-selectin as a signaling molecule. J Biol Chem (1994) 1.33
Virulence factors of avian Escherichia coli. Avian Dis (1990) 1.31
Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. J Neuroimmunol (1999) 1.25
The Italian Longitudinal Study on Aging (ILSA): design and methods. Aging (Milano) (1994) 1.20
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Prolactin-releasing effect of domperidone in normoprolactinemic and hyperprolactinemic subjects. Neuroendocrinology (1980) 1.19
Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin). Clin Endocrinol (Oxf) (1990) 1.19
Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab (2006) 1.17
Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol. Eur J Endocrinol (2001) 1.17
Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses. J Clin Endocrinol Metab (1974) 1.15
DNA methylation in repetitive elements and Alzheimer disease. Brain Behav Immun (2011) 1.15
Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2. Clin Genet (2011) 1.14
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. Mult Scler (2011) 1.11
The involvement of cyclic 3',5'-adenosine monophosphate in the growth hormone release mechanism (s). Experientia (1969) 1.10
Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways. Curr Cancer Drug Targets (2009) 1.10
HLA-class I markers and multiple sclerosis susceptibility in the Italian population. Genes Immun (2009) 1.09
Enterotoxigenicity of Staphylococcus intermedius of canine origin. Int J Food Microbiol (1988) 1.09
Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol (1998) 1.08
Analysis of fibronectin expression during human muscle differentiation. Basic Appl Histochem (1986) 1.08
Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications. Drugs (1983) 1.06
Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysis. Int J Obes Relat Metab Disord (1998) 1.06
Novel exon 1 progranulin gene variant in Alzheimer's disease. Eur J Neurol (2008) 1.03
Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration. Neurology (2006) 1.02
Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-alpha-ergocryptine (CB-154) in acromegalic patients. J Clin Endocrinol Metab (1975) 1.01
Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary (2001) 1.00
D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord (2007) 0.99
Blockade of release of growth hormone by brain norepinephrine depletors. Endocrinology (1967) 0.98
Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology (1999) 0.98
Influence of brain neurohumors injected into the lateral ventricle of the rat on growth hormone release. Endocrinology (1968) 0.97
Variations of the perforin gene in patients with multiple sclerosis. Genes Immun (2008) 0.96
Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol (2012) 0.96
Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients. Clin Endocrinol (Oxf) (1976) 0.96
[Endothelial keratopathy in pseudoexfoliation syndrome: quantitative and qualitative morphometry using automated video image analysis]. Klin Monbl Augenheilkd (1995) 0.95
Effect of an antiserotoninergic drug, metergoline, on the ACTH and cortisol response to insulin hypoglycemia and lysine-vasopressin in man. J Clin Endocrinol Metab (1976) 0.95
Myosin subunit composition in human developing muscle. Biochem J (1984) 0.95
Inferior petrosal sinus sampling in the differential diagnosis of Cushing's syndrome: results of an Italian multicenter study. Eur J Endocrinol (2001) 0.94
Clonidine treatment for short stature. Lancet (1987) 0.93
Multiple sclerosis and mitochondrial myopathy: an unusual combination of diseases. J Neurol (1994) 0.93
The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration. Eur J Neurol (2009) 0.92
Diagnosis and treatment of acromegaly complications. J Endocrinol Invest (2003) 0.90
Hypoglycemia, stress and growth hormone release: blockade of growth hormone release by drugs acting on the central nervous system. Endocrinology (1967) 0.90
The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states. J Clin Endocrinol Metab (2000) 0.90
A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy. Genes Immun (2007) 0.89
Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in man. Acta Endocrinol (Copenh) (1980) 0.89
Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort. Eur J Neurol (2010) 0.89
Mesenteric-portal vein thrombosis in a patient with hyperhomocysteinemia and heterozygous for 20210A prothrombin allele. Thromb Haemost (2000) 0.89
One month of streptozotocin-diabetes induces different neuroendocrine and morphological alterations in the hypothalamo-pituitary axis of male and female rats. Endocrinology (1985) 0.89
Thyrotrophin releasing hormone-induced growth hormone and prolactin release: physiological studies in intact rats and in hypophysectomized rats bearing an ectopic pituitary gland. J Endocrinol (1977) 0.89
Spontaneous nocturnal growth hormone secretion in anorexia nervosa. J Clin Endocrinol Metab (1997) 0.89
Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia. Clin Endocrinol (Oxf) (1983) 0.89
S-100 protein and laminin: immunocytochemical markers for human Schwann cells in vitro. Exp Neurol (1986) 0.88
The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with beta-amyloid protein. Neurosci Lett (2000) 0.88
Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients. Diabetes Obes Metab (2007) 0.88
Disruption of friend of GATA 2 gene (FOG-2) by a de novo t(8;10) chromosomal translocation is associated with heart defects and gonadal dysgenesis. Clin Genet (2007) 0.88
A central site for the hyperglycemic action of 2-deoxy-d-glucose in mouse and rat. Life Sci I (1971) 0.88
Severe polyneuropathy in a patient with Churg-Strauss syndrome. J Peripher Nerv Syst (2000) 0.88
Letter: Reduction of food intake by apomorphine: a pimozide-sensitive effect. J Pharm Pharmacol (1973) 0.87
EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease. Eur J Neurol (2015) 0.87
Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. J Clin Endocrinol Metab (1997) 0.86
Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat. Life Sci (1978) 0.86
Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: blockade of motor neuron death in the wobbler mouse. Neuroscience (1999) 0.86
Leu-enkephalin-stimulated growth hormone and prolactin release in the rat: comparison with the effect of morphine. Life Sci (1977) 0.86
Growth hormone and prolactin responses to thyrotropin-releasing hormone in patients with severe liver disease. J Clin Endocrinol Metab (1977) 0.85
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. Neurol Sci (2013) 0.85
Nomifensine: diagnostic test in hyperprolactinemic states. J Clin Endocrinol Metab (1978) 0.85
MDC/CCL22 intrathecal levels in patients with multiple sclerosis. Mult Scler (2008) 0.85
Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma. Biochem Biophys Res Commun (1999) 0.84
Visual loss and enlarged extraocular muscles from metastatic signet ring carcinoma. J Neurol (2001) 0.84
Defective regulation of prolactin secretion after successful removal of prolactinomas. J Clin Endocrinol Metab (1983) 0.84